Insights from Morgans Institutional Conference in Noosa, Queensland

In mid-October, Morgans had the privilege of hosting its annual Institutional Conference in the serene backdrop of Noosa, Queensland. This year marked the 33rd edition of our Queensland Conference, bringing together 42 prominent companies representing diverse sectors of the Australian economy.

Featured Companies

We spotlight three noteworthy companies that left an indelible mark on our Conference: Corporate Travel Management (CTD), Eagers Automotive (APE), and Monash IVF Group (MVF).

Corporate Travel Management (CTD)

CTD is benefitting from new client wins transacting. Importantly its larger clients are gradually travelling more. With airfares coming down, corporate travel is becoming more affordable, so budgets aren’t used up earlier. Airline and airport reliability continues to improve, helping corporate travel recover, with day trips slowly returning.


Eagers Automotive (APE)

Demand in the underlying business remains solid. Recovering supply is indicating a record year of deliveries in Australia, with APE expecting a stronger margin outcome (LFL basis) for FY23 compared to FY22. The recent acquisition has provided an opportunity to improve margins and will add significant turnover from 2024. APE is bolstered by the opportunities of ongoing consolidation and original equipment manufacturers pointing to fewer dealers.


Monash IVF Group (MVF)

The post-COVID boom in IVF industry cycle volumes has been sustained. It should continue to grow from here, driven by tailwinds in the underlying growth drivers – increased maternal age, egg freezing, increase in LGBTIQ+ couples, and increased government support for genetic testing. There has been some movement in fertility specialists due to a change in ownership amongst peers, Monash has been a beneficiary and expects there to be some movement still.


Morgans clients receive exclusive insights such as access to the latest stock and sector coverage featured in the Month Ahead. Contact us today to begin your journey with Morgans.

      
Contact Us
      

Disclaimer: The information contained in this report is provided to you by Morgans Financial Limited as general advice only, and is made without consideration of an individual's relevant personal circumstances. Morgans Financial Limited ABN 49 010 669 726, its related bodies corporate, directors and officers, employees, authorised representatives and agents (“Morgans”) do not accept any liability for any loss or damage arising from or in connection with any action taken or not taken on the basis of information contained in this report, or for any errors or omissions contained within. It is recommended that any persons who wish to act upon this report consult with their Morgans investment adviser before doing so.

News & Insights

Our best ideas are those that we think offer the highest risk-adjusted returns over a 12-month timeframe supported by a higher-than-average level of confidence. They are our most preferred sector exposures.
Read full article
Our banks analyst Nathan Lead recently had a close look at the valuations of the banks to see if their recent share price strength could be justified by fundamentals.
Read full article
Our best ideas are those that we think offer the highest risk-adjusted returns over a 12-month timeframe supported by a higher-than-average level of confidence. They are our most preferred sector exposures.
Read full article

News & Insights

Explore the insights from the Morgans Institutional Conference on the evolving corporate landscape in Australia. Discover the growth trajectories and strategies of Corporate Travel Management (CTD), Eagers Automotive (APE), and Monash IVF Group (MVF).
Find out more